<DOC>
	<DOCNO>NCT02015637</DOCNO>
	<brief_summary>The purpose study evaluate effect single oral dose delafloxacin versus single intramuscular injection ceftriaxone subject uncomplicated cervical , urethral , rectal , pharyngeal gonorrhea .</brief_summary>
	<brief_title>Comparison Delafloxacin Versus Ceftriaxone Treatment Uncomplicated Gonorrhea</brief_title>
	<detailed_description />
	<mesh_term>Gonorrhea</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<criteria>Subject male female 15 year age old . Subject must 1 follow occur : 1. gonorrhea NAAT culture within previous 14 day 2. unprotected genital contact within 14 day person confirm infected gonorrhea , 3. gramnegative present urogenital gram strain male subject must present purulent urethritis female subject must present mucopurulent cervical discharge Subject agree avoid unprotected sexual contact order minimize risk gonorrhea reinfection Subject must good health ( ie , base medical history ) , determine investigator . In opinion investigator , subject must able willing comply protocol requirement . The subject must agree provide reliable , verifiable contact information agree return TestofCure Visit . If subject 's age 15 year less legal age consent , write , voluntarily sign assent must obtain subject write , voluntarily sign informed consent must sign subject 's parent legal guardian initiation study related procedure , unless IRB/IEC determine parent/legal guardian consent require . Confirmed , suspect , complicate systemic gonococcal infection , pelvic inflammatory disease , arthritis , endocarditis . Subject take one follow product within 6 hour Entry Visit may interfere absorption quinolone antibiotic : magnesium/aluminum antacid ; sucralfate ; VidexÂ® ( didanosine ) chewable/buffered tablet ; highly buffer drug ; product contain calcium , iron , zinc . Use systemic intravaginal antibiotic potentially effective gonorrhea 4 week prior study drug administration . Subjects current prior history seizure , subject treat drug know sizable potential reduce threshold inducing seizure ( eg , bupropion , theophylline , tricyclic tetracyclic antidepressant ) . Current use systemic corticosteroid immunosuppressive drug . Known significant immunosuppression ( eg , CD4 cell count &lt; 200/mm3 absolute neutrophil count &lt; 500/mL ) . Cytotoxic chemotherapy radiation therapy previous 3 month . Subject coinfected additional sexually transmitted disease ( STD ) treatment safely deferred TestofCure Visit unless treatment potentially effective gonorrhea . Subject use investigational drug product within 30 day study drug dose . Medical history Type 1 hypersensitivity antibiotic quinolone cephalosporin class . Hysterectomized subject without cervix ineligible .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Gonorrhea</keyword>
	<keyword>N. gonorrhoeae</keyword>
	<keyword>bacterial infection</keyword>
	<keyword>Anti-Infective Agents</keyword>
	<keyword>Anti-Bacterial Agents</keyword>
</DOC>